WMK Stock Analysis: Weis Markets | NYSE
Grocery Stores | NYSE, USA | Market Cap: 1.986m USD | 12M Return: 5.8% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 15.2M
EPS Trend: -27.2%
Rev. Trend: 84.8%
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Weis Markets is a regional supermarket operator founded in 1912 and headquartered in Sunbury, Pennsylvania. The company runs a chain of food stores across seven Mid-Atlantic and Northeastern states (Delaware, Maryland, New Jersey, New York, Pennsylvania, Virginia, and West Virginia), offering a full range of grocery items, dairy, frozen foods, meat and seafood, fresh produce, floral, deli, prepared meals, bakery items, beer and wine, and fuel, alongside general merchandise such as health, beauty, and household products.
The company also operates in-store pharmacies and supports multiple store banners, including Weis Markets, Weis 2 Go, Weis Great Meals Start Here, Weis Gas-n-Go, and Weis Nutri-Facts. Weis Markets trades on the NYSE under the ticker WMK, is classified in the GICS Consumer Staples sector within the Food Retail sub-industry, and went public in 1988.
As a food retailer, Weis operates in a defensive segment of consumer staples, where demand is typically less sensitive to economic cycles. The integration of pharmacy services and fuel stations into its store base reflects a common supermarket industry strategy of using higher-margin, higher-traffic complementary categories to support overall profitability beyond core grocery sales.
- Same-store sales growth in core Mid-Atlantic grocery markets
- Food deflation pressures grocery margins amid competitive pricing
- Fuel center and pharmacy operations drive incremental revenue
| Net Income: 101.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 1.42 > 1.0 |
| NWC/Revenue: 6.86% < 20% (prev 9.98%; Δ -3.11% < -1%) |
| CFO/TA 0.11 > 3% & CFO 232.6m > Net Income 101.1m |
| Net Debt (-25.1m) to EBITDA (246.4m): -0.10 < 3 |
| Current Ratio: 2.04 > 1.5 & < 3 |
| Outstanding Shares: last quarter (24.7m) vs 12m ago -8.01% < -2% |
| Gross Margin: 23.10% > 18% (prev 25.26%; Δ -2.16% > 0.5%) |
| Asset Turnover: 244.0% > 50% (prev 231.5%; Δ 12.56% > 0%) |
| Interest Coverage Ratio: 8.15 > 6 (EBIT TTM 119.8m / Interest Expense TTM 14.7m) |
| A: 0.17 (Total Current Assets 674.6m - Total Current Liabilities 330.6m) / Total Assets 2.03b |
| B: 0.82 (Retained Earnings 1.66b / Total Assets 2.03b) |
| C: 0.06 (EBIT TTM 119.8m / Avg Total Assets 2.05b) |
| D: 2.09 (Book Value of Equity 1.37b / Total Liabilities 656.3m) |
| Altman-Z'' = 6.36 = AAA |
| DSRI: 1.15 (Receivables 98.2m/81.9m, Revenue 5.01b/4.82b) |
| GMI: 1.09 (GM 25.26% / 23.10%) |
| AQI: 1.03 (AQ_t 0.04 / AQ_t-1 0.04) |
| SGI: 1.04 (Revenue 5.01b / 4.82b) |
| TATA: -0.06 (NI 101.1m - CFO 232.6m) / TA 2.03b) |
| Beneish M = -2.78 (Cap -4..+1) = A |
As of July 14, 2026, the stock is trading at USD 78.69 with a total of 122,016 shares traded. Over the past week, the price has changed by -1.97%, over one month by -0.69%, over three months by +11.13% and over the past year by +5.77%.
Current recommended Stop Loss: 73.80 (which is 6.2% or 2.2 ATR below the current price).
Weis Markets has no consensus analysts rating.
| Analysts Target Price | 31 | -60.6% |
P/E Trailing = 19.8198
P/E Forward = 8.6806
P/S = 0.3962
P/B = 1.4461
P/EG = 1.3815
Revenue TTM = 5.01b USD
EBIT TTM = 119.8m USD
EBITDA TTM = 246.4m USD
Long Term Debt = 134.1m USD (estimated: total debt 173.8m - short term 39.7m)
Short Term Debt = 39.7m USD (from shortTermDebt, last quarter)
Debt = 173.8m USD (from shortLongTermDebtTotal, last quarter) (leases 173.8m already included)
Net Debt = -25.1m USD (calculated: Debt 173.8m - CCE 198.8m)
Enterprise Value = 1.96b USD (1.99b + Debt 173.8m - CCE 198.8m)
Interest Coverage Ratio = 8.15 (Ebit TTM 119.8m / Interest Expense TTM 14.7m)
EV/FCF = 81.46x (Enterprise Value 1.96b / FCF TTM 24.1m)
FCF Yield = 1.23% (FCF TTM 24.1m / Enterprise Value 1.96b)
FCF Margin = 0.48% (FCF TTM 24.1m / Revenue TTM 5.01b)
Net Margin = 2.02% (Net Income TTM 101.1m / Revenue TTM 5.01b)
Gross Margin = 23.10% ((Revenue TTM 5.01b - Cost of Revenue TTM 3.86b) / Revenue TTM)
Gross Margin QoQ = 26.30% (prev 16.25%)
Tobins Q-Ratio = 0.97 (Enterprise Value 1.96b / Total Assets 2.03b)
Interest Expense / Debt = 8.46% (Interest Expense 14.7m / Debt 173.8m)
Taxrate = 24.31% (32.5m / 133.5m)
NOPAT = 90.7m (EBIT 119.8m * (1 - 24.31%))
Current Ratio = 2.04 (Total Current Assets 674.6m / Total Current Liabilities 330.6m)
Debt / Equity = 0.13 (Debt 173.8m / totalStockholderEquity, last quarter 1.37b)
Debt / EBITDA = -0.10 (Net Debt -25.1m / EBITDA 246.4m)
Debt / FCF = -1.04 (Net Debt -25.1m / FCF TTM 24.1m)
Total Stockholder Equity = 1.35b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.92% (Net Income 101.1m / Total Assets 2.03b)
RoE = 7.49% (Net Income TTM 101.1m / Total Stockholder Equity 1.35b)
RoCE = 8.08% (EBIT 119.8m / Capital Employed (Equity 1.35b + L.T.Debt 134.1m))
RoIC = 5.90% (NOPAT 90.7m / Invested Capital 1.54b)
WACC = 4.90% (E(1.99b)/V(2.16b) * Re(4.77%) + D(173.8m)/V(2.16b) * Rd(8.46%) * (1-Tc(0.24)))
Discount Rate = 4.77% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -74.74 | Cagr: -3.64%
[DCF] Terminal Value 75.44% ; FCFF base≈24.1m ; Y1≈24.2m ; Y5≈25.6m
[DCF] Fair Price = 17.11 (EV 398.3m - Net Debt -25.1m = Equity 423.3m / Shares 24.7m; r=8.35% [WACC [floored]]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: -27.20 | EPS CAGR: -2.04% | SUE: N/A | # QB: 0
Revenue Correlation: 84.80 | Revenue CAGR: 1.86% | SUE: N/A | # QB: 0